You are here: Industry Insights > drug prices

News List

Trump's drug-prices-in-ads idea gets two more nay votes as federal comment deadline looms fiercepharma
December 05, 2018
In the latest salvos challenging the value of adding drug prices to pharma TV ads, two academics and a well-known advertising association have set out their arguments against the proposal.
API: Expensive Drugs to Arrive! Jinsenshui
August 22, 2018
The State Council of China released the Notice on Issuing the Opinions on Pushing Forward the Pharmaceutical Pricing Reform in 2015 to cancel...
UK-US post-Brexit trade deal risks increased drug prices europeanpharmaceuticalreview
July 16, 2018
A trade deal between the UK and USA could risk increasing drug prices in the UK, which could diminish the affordability and accessibility of the NHS…
Is the Push for Lower Drug Prices Surging Again? biospace
April 27, 2018
During the 2016 U.S. presidential election, the push for lower drug prices became one of the hot-button topics.
Doctors Accuse NextSource Biotech for Hiking the Price on Key Cancer Drug Nine Times biospace
December 29, 2017
The cost of a vital cancer drug has gone up 15-fold in four years after its new owner hiked prices on nine separate occasions
Biopharma trends to watch in 2018 biopharmadive
December 27, 2017
The drug pricing debate will likely stay in the headlines in the new year, while M&A could get a jumpstart after Congress passed a new tax law that could make deals more lucrative.
What Trump should do if he actually wants to cut drug prices newsday
November 27, 2017
President Donald Trump nominated Alex Azar to serve the next secretary of health and human services last week, tweeting that he would be “a star for better healthcare and lower drug prices!”
Amid FDA competition push, Hikma jacks up a handful of drug prices as much as 430% fiercepharma
August 22, 2017
West-Ward says the prices on 94% of its drugs have stayed the same or dropped this year, but prices of six drugs went up this month as much as fourfold.
Has the Brent Saunders price-hike limit become a de facto pharma rule? fiercepharma
August 15, 2017
Allergan CEO Brent Saunders' pledge to limit price hikes has distinctly affected the industry's pricing practices, data from Bernstein show.

Previous page 1 2 3 4 Next page